Seoul: Samsung Biologics Co. on Wednesday reported its 2024 net profit of 1.08 trillion won (US$753.2 million), marking a 26.3 percent increase from the previous year.
According to Yonhap News Agency, the company disclosed in a regulatory filing that it achieved an operating profit of 1.32 trillion won for the year, compared to 1.11 trillion won in the prior year. Additionally, its annual revenue experienced a rise of 23.1 percent, reaching 4.54 trillion won.